Editas Medicine (EDIT) EBT Margin Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,297.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13.24 Mn |
| Jun 30, 2025 | -59,482.00 |
| Mar 31, 2025 | -88,177.00 |
| Dec 31, 2024 | 18,398.00 |
| Sep 30, 2024 | -10.12 Mn |
| Jun 30, 2024 | 140,060.00 |
| Mar 31, 2024 | -458,548.00 |
| Dec 31, 2023 | 54,346.00 |
| Sep 30, 2023 | -85,835.00 |
| Jun 30, 2023 | -110,928.00 |
| Mar 31, 2023 | 30,560.00 |
| Dec 31, 2022 | -62,169.00 |
| Sep 30, 2022 | -13.18 Mn |
| Jun 30, 2022 | 60,324.00 |
| Mar 31, 2022 | 66,896.00 |
| Dec 31, 2021 | 7,709.00 |
| Sep 30, 2021 | -52,604.00 |
| Jun 30, 2021 | -1.41 Mn |
| Mar 31, 2021 | -8,071.00 |
| Sep 30, 2020 | 44,120.00 |
| Jun 30, 2020 | 57,159.00 |
| Mar 31, 2020 | 379,291.00 |
| Dec 31, 2019 | 407,343.00 |
| Sep 30, 2019 | 133,015.00 |
| Jun 30, 2019 | -88,493.00 |
| Mar 31, 2019 | 78,907.00 |
| Dec 31, 2018 | 115,714.00 |
| Sep 30, 2018 | 100,343.00 |
| Jun 30, 2018 | 571,815.00 |